The Harvest Smart PRePTM system versus the Friadent-Schütze platelet-rich plasma kit
- PMID: 12656885
- DOI: 10.1034/j.1600-0501.2003.140215.x
The Harvest Smart PRePTM system versus the Friadent-Schütze platelet-rich plasma kit
Abstract
An important reason to improve methods for isolating platelet-rich plasma (PRP) is the potential use of autogenous platelet growth factors. In addition to the Curasan PRP kit (Curasan, Kleinostheim, Germany) and the platelet concentrated collection system (PCCSTM) system, two new methods for the preparation of PRP by the surgeon are now available. This study compared the suitability of these new methods for the preparation of PRP. Whole blood was drawn from 54 healthy donors (33 men and 21 women) aged 23-79 years (38.0 +/- 17.7 years). PRP was prepared from each donor's blood using both the Smart PRePTM system (Harvest Technologies Corporation, Munich, Germany) and the Friadent-Schütze method (PRP kit; Friadent-Schütze, Vienna, Austria). The platelet count in donor whole blood was 276 810 +/- 59 440 /microl. Platelet counts differed significantly between the Smart PRP preparation (1227 890 +/- 312 440 platelets/microl) and the Friadent-Schütze PRP preparation (1440 500 +/- 501 700 platelets/microl) (sign test, P < 0.001). The Smart PRePTM system had a significantly higher collection efficiency (63.4 +/- 7.9%) than the Friadent-Schütze kit (49.6 +/- 13.6%) (sign test, P < 0.001). The leukocyte contents in the two platelet concentrates were similar (Smart PRePTM, 19 261 +/- 8082 platelets/microl; Friadent-Schütze, 21 691 +/- 16 430). Transforming growth factor (TGF)-beta1 and platelet-derived growth factor (PDGF)-AB were higher in the Friadent-Schütze PRP (TGF-beta1, 196.8 +/- 109.6 ng/ml; PDGF-AB, 251.6 +/- 115.4 ng/ml) than in the Smart PRePTM (TGF-beta1, 77.2 +/- 54.8 ng/ml; PDGF-AB, 208 +/- 85.2 ng/ml). The sign test indicated significant differences between the two methods in the concentrations of TGF-beta1 (P < 0.001) and PDGF-AB (P < 0.01). Insulin-like growth factor (IGF)-1 levels in the two PRP preparations were similar (Friadent-Schütze PRP, 72.8 +/- 22.3 ng/ml; Smart PRePTM, 91.4 +/- 21.3 ng/ml). The Smart PRePTM system was superior with respect to ease of handling and preparation time. It also had a significantly higher platelet collection efficiency than the Friadent-Schütze PRePTM kit. The Friadent-Schütze PRP kit offers a slight advantage in the resulting PRP platelet concentration. However, this is easily compensated for in the Smart PRePTM system by reducing the volume of the resulting PRP.
Similar articles
-
Growth factor levels in the platelet-rich plasma produced by 2 different methods: curasan-type PRP kit versus PCCS PRP system.Int J Oral Maxillofac Implants. 2002 Mar-Apr;17(2):184-90. Int J Oral Maxillofac Implants. 2002. PMID: 11958400
-
Comparison of platelet, leukocyte, and growth factor levels in point-of-care platelet-enriched plasma, prepared using a modified Curasan kit, with preparations received from a local blood bank.Clin Oral Implants Res. 2003 Jun;14(3):357-62. doi: 10.1034/j.1600-0501.2003.00810.x. Clin Oral Implants Res. 2003. PMID: 12755786
-
Comparison of the platelet concentrate collection system with the plasma-rich-in-growth-factors kit to produce platelet-rich plasma: a technical report.Int J Oral Maxillofac Implants. 2005 Jan-Feb;20(1):118-23. Int J Oral Maxillofac Implants. 2005. PMID: 15747683
-
Concentrations of Blood Components in Commercial Platelet-Rich Plasma Separation Systems: A Review of the Literature.Am J Sports Med. 2019 Feb;47(2):479-487. doi: 10.1177/0363546517746112. Epub 2018 Jan 16. Am J Sports Med. 2019. PMID: 29337592 Review.
-
Growth factor content in PRP and their applicability in medicine.J Biol Regul Homeost Agents. 2012 Apr-Jun;26(2 Suppl 1):3S-22S. J Biol Regul Homeost Agents. 2012. PMID: 23648195 Review.
Cited by
-
Platelet Concentrates in Musculoskeletal Medicine.Int J Mol Sci. 2020 Feb 16;21(4):1328. doi: 10.3390/ijms21041328. Int J Mol Sci. 2020. PMID: 32079117 Free PMC article. Review.
-
Serial intraarticular injections of growth factor concentrate in knee osteoarthritis: A placebo controlled randomized study.J Orthop. 2023 Feb 14;37:46-52. doi: 10.1016/j.jor.2023.02.006. eCollection 2023 Mar. J Orthop. 2023. PMID: 36974096 Free PMC article.
-
Differences between first- and second-generation autologous platelet concentrates.Periodontol 2000. 2025 Feb;97(1):52-73. doi: 10.1111/prd.12550. Epub 2024 Mar 15. Periodontol 2000. 2025. PMID: 38487938 Free PMC article. Review.
-
Evaluation of the effect of calcium gluconate and bovine thrombin on the temporal release of transforming growth factor beta 1 and platelet-derived growth factor isoform BB from feline platelet concentrates.BMC Vet Res. 2012 Nov 6;8:212. doi: 10.1186/1746-6148-8-212. BMC Vet Res. 2012. PMID: 23131192 Free PMC article.
-
Comparison of the effect of calcium gluconate and batroxobin on the release of transforming growth factor beta 1 in canine platelet concentrates.BMC Vet Res. 2012 Jul 25;8:121. doi: 10.1186/1746-6148-8-121. BMC Vet Res. 2012. PMID: 22830991 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous